ATE370733T1 - Pharmazeutische kombinationspräparat zur behandlung von spastischkeit und/oder schmerzen - Google Patents
Pharmazeutische kombinationspräparat zur behandlung von spastischkeit und/oder schmerzenInfo
- Publication number
- ATE370733T1 ATE370733T1 AT04726223T AT04726223T ATE370733T1 AT E370733 T1 ATE370733 T1 AT E370733T1 AT 04726223 T AT04726223 T AT 04726223T AT 04726223 T AT04726223 T AT 04726223T AT E370733 T1 ATE370733 T1 AT E370733T1
- Authority
- AT
- Austria
- Prior art keywords
- spasticity
- treatment
- pain
- pharmaceutical combination
- combination preparation
- Prior art date
Links
- 208000008238 Muscle Spasticity Diseases 0.000 title abstract 2
- 208000018198 spasticity Diseases 0.000 title abstract 2
- MKXZASYAUGDDCJ-SZMVWBNQSA-N LSM-2525 Chemical compound C1CCC[C@H]2[C@@]3([H])N(C)CC[C@]21C1=CC(OC)=CC=C1C3 MKXZASYAUGDDCJ-SZMVWBNQSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229960001985 dextromethorphan Drugs 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0300929A HUP0300929A3 (en) | 2003-04-09 | 2003-04-09 | Analgetic and/or muscle relaxant pharmaceutical composition |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE370733T1 true ATE370733T1 (de) | 2007-09-15 |
Family
ID=90001682
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04726223T ATE370733T1 (de) | 2003-04-09 | 2004-04-07 | Pharmazeutische kombinationspräparat zur behandlung von spastischkeit und/oder schmerzen |
Country Status (16)
Country | Link |
---|---|
US (1) | US20060199841A1 (de) |
EP (1) | EP1610785B1 (de) |
JP (1) | JP2006522786A (de) |
AT (1) | ATE370733T1 (de) |
CY (1) | CY1106903T1 (de) |
DE (1) | DE602004008440T2 (de) |
DK (1) | DK1610785T3 (de) |
EA (1) | EA007732B1 (de) |
ES (1) | ES2293245T3 (de) |
HR (1) | HRP20070441T3 (de) |
HU (1) | HUP0300929A3 (de) |
NO (1) | NO20055254L (de) |
PL (1) | PL1610785T3 (de) |
PT (1) | PT1610785E (de) |
RS (1) | RS20050738A (de) |
WO (1) | WO2004089352A2 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1395289T3 (da) * | 2001-06-07 | 2011-03-28 | Christine Dr Sang | Behandling af neuropatisk smerte med en N-methyl-D-aspartat- (NMDA-)receptorantagonist |
US8262942B2 (en) | 2008-02-07 | 2012-09-11 | The George Washington University | Hollow carbon nanosphere based secondary cell electrodes |
TR201720289A2 (tr) * | 2017-12-13 | 2019-06-21 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Tolperizon Ve Selektif COX-2 İnhibitörü Kombinasyonları |
JP7169580B2 (ja) * | 2018-09-27 | 2022-11-11 | 株式会社Lttバイオファーマ | 線維症治療用医薬組成物 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5340779A (en) * | 1976-09-21 | 1978-04-13 | Nippon Kayaku Co Ltd | Optically active tolpertisone, their preparation and pharmaceuticals containting the same |
AU2929489A (en) * | 1987-12-22 | 1989-07-19 | John W. FERKANY | Dextrorphan potentiator for anticonvulsant composition and method |
US4906638A (en) * | 1987-12-22 | 1990-03-06 | Nova Pharmaceutical Corporation | Dextromethorphan potentiator for anticonvulsant composition and method |
US5206248A (en) * | 1992-03-27 | 1993-04-27 | Smith Richard A | Method for reducing emotional lability |
EP1634597A1 (de) * | 1994-09-22 | 2006-03-15 | Richard Alan Smith | Dextromethorphan und Quinidin oder Quinine enthaltende Zusammensetzungen zur Behandlung der Gemütslabilität |
US5840731A (en) * | 1995-08-02 | 1998-11-24 | Virginia Commonwealth University | Pain-alleviating drug composition and method for alleviating pain |
AUPN605795A0 (en) * | 1995-10-19 | 1995-11-09 | F.H. Faulding & Co. Limited | Analgesic pharmaceutical composition |
CA2264182A1 (en) * | 1996-08-23 | 1998-02-26 | Algos Pharmaceutical Corporation | Anticonvulsant containing composition for treating neuropathic pain |
AT409083B (de) * | 1999-04-01 | 2002-05-27 | Sanochemia Pharmazeutika Ag | Pharmazeutische, tolperison enthaltende zubereitung zur oralen verabreichung |
DE10123129A1 (de) * | 2001-05-02 | 2002-11-14 | Berolina Drug Dev Ab Svedala | Deuterierte 3-Piperidinopropiophenone sowie diese Verbindungen enthaltende Arzneimittel |
-
2003
- 2003-04-09 HU HU0300929A patent/HUP0300929A3/hu unknown
-
2004
- 2004-04-07 WO PCT/HU2004/000032 patent/WO2004089352A2/en active IP Right Grant
- 2004-04-07 PT PT04726223T patent/PT1610785E/pt unknown
- 2004-04-07 DK DK04726223T patent/DK1610785T3/da active
- 2004-04-07 EP EP04726223A patent/EP1610785B1/de not_active Expired - Lifetime
- 2004-04-07 EA EA200501591A patent/EA007732B1/ru not_active IP Right Cessation
- 2004-04-07 RS YUP-2005/0738A patent/RS20050738A/sr unknown
- 2004-04-07 ES ES04726223T patent/ES2293245T3/es not_active Expired - Lifetime
- 2004-04-07 US US10/551,510 patent/US20060199841A1/en not_active Abandoned
- 2004-04-07 DE DE602004008440T patent/DE602004008440T2/de not_active Expired - Fee Related
- 2004-04-07 JP JP2006506245A patent/JP2006522786A/ja not_active Withdrawn
- 2004-04-07 PL PL04726223T patent/PL1610785T3/pl unknown
- 2004-04-07 AT AT04726223T patent/ATE370733T1/de not_active IP Right Cessation
-
2005
- 2005-11-08 NO NO20055254A patent/NO20055254L/no not_active Application Discontinuation
-
2007
- 2007-09-25 HR HR20070441T patent/HRP20070441T3/xx unknown
- 2007-10-02 CY CY20071101259T patent/CY1106903T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE602004008440T2 (de) | 2008-05-21 |
CY1106903T1 (el) | 2012-09-26 |
ES2293245T3 (es) | 2008-03-16 |
HUP0300929A2 (hu) | 2005-02-28 |
NO20055254L (no) | 2006-01-06 |
WO2004089352A2 (en) | 2004-10-21 |
DK1610785T3 (da) | 2007-10-22 |
NO20055254D0 (no) | 2005-11-08 |
EA200501591A1 (ru) | 2006-06-30 |
DE602004008440D1 (de) | 2007-10-04 |
HUP0300929A3 (en) | 2005-06-28 |
EP1610785A2 (de) | 2006-01-04 |
HUP0300929D0 (en) | 2003-06-28 |
US20060199841A1 (en) | 2006-09-07 |
EP1610785B1 (de) | 2007-08-22 |
JP2006522786A (ja) | 2006-10-05 |
HRP20070441T3 (en) | 2007-10-31 |
PL1610785T3 (pl) | 2008-01-31 |
PT1610785E (pt) | 2007-09-10 |
EA007732B1 (ru) | 2006-12-29 |
RS20050738A (en) | 2008-04-04 |
WO2004089352A3 (en) | 2004-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0022438D0 (en) | Organic Compounds | |
TW200615266A (en) | Organic compounds | |
ATE457027T1 (de) | Substituierte 1,4,8-triazaspiroä4.5 decan-2-on- verbindungen zur behandlung von fettsucht | |
TNSN04203A1 (en) | Benzoxazinone-derived compounds, their preparation and use as medicaments | |
UA85708C2 (ru) | Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей | |
DE502005008058D1 (de) | Gesättigte und ungesättigte 3-pyridyl-benzocycloalkylmethyl-amine zur behandlung von schmerzen, depressionen und angstzuständen | |
ATE433450T1 (de) | Substituierte 1,4,8-triazaspiro 4.5 decan-2-on- verbindungen | |
ATE502631T1 (de) | Verbindungen zur behandlung von stoffwechselstörungen | |
NO20055254D0 (no) | Farmasoytisk kombinasjon for behandling av spastisitet og/eller smerte | |
GB0012795D0 (en) | Organic compounds | |
DE602004029993D1 (de) | Pharmazeutische zusammensetzung zur behandlung von drogenabhängigkeit | |
MY136965A (en) | 1,4-disubstituted piperidine compounds, their preparation and use as medicaments | |
DE502007006951D1 (de) | Arzneimittelkombinationen zur behandlung von atemwegserkrankungen | |
ATE543495T1 (de) | Pharmazeutische zusammensetzung mit einer ruthenium-oxalato-verbindung und anwendungsverfahren dafür | |
UA81405C2 (en) | Substituted pyridinones as modulators of p38 map kinase | |
ATE401081T1 (de) | Ammoniumsalze von ornithin-derivaten zur behandlung von enzündlichen erkrankungen | |
IS6416A (is) | Fjórgild ammóníum og notkun þeirra sem miðlar gegn hósta | |
TH62500A (th) | Nk1 แอนทาโกนิสท์ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1610785 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |